Merck Gets Positive EU CHMP Opinion for Two New Regimens of Keytruda

Date : 10/18/2019 @ 11:50AM
Source : Dow Jones News
Stock : Merck and Co Inc (MRK)
Quote : 84.82  0.7 (0.83%) @ 9:11PM
After Hours
Last Trade
Last $ 84.82 ◊ 0.00 (0.00%)

Merck Gets Positive EU CHMP Opinion for Two New Regimens of Keytruda

Merck (NYSE:MRK)
Historical Stock Chart

1 Month : From Oct 2019 to Nov 2019

Click Here for more Merck Charts.

By Michael Dabaie


Merck & Co. (MRK) said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended approval of two regimens of Keytruda for the first-line treatment of metastatic or unresectable recurrent head and neck squamous cell carcinoma.

Keytruda, as monotherapy or in combination with platinum and 5-fluorouracil chemotherapy, is recommended in patients whose tumors express PD-L1, said the Kenilworth, N.J., company, which is known as MSD outside the U.S. and Canada.

The CHMP recommendation is based on data from the pivotal Phase 3 KEYNOTE-048 trial, in which Keytruda demonstrated a significant improvement in overall survival, compared with standard treatment.

The European Commission for marketing authorization in the EU will now review the CHMP's recommendation and a final decision is expected in the fourth quarter of 2019, Merck said.


Write to Michael Dabaie at


(END) Dow Jones Newswires

October 18, 2019 07:35 ET (11:35 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest MRK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.